1
|
Son YB, Jeong YI, Jeong YW, Olsson PO, Hossein MS, Cai L, Kim S, Choi EJ, Sakaguchi K, Tinson A, Singh KK, Rajesh S, Noura AS, Hwang WS. Development and pregnancy rates of Camelus dromedarius-cloned embryos derived from in vivo- and in vitro-matured oocytes. Anim Biosci 2021; 35:177-183. [PMID: 34289583 PMCID: PMC8738946 DOI: 10.5713/ab.21.0131] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Accepted: 05/28/2021] [Indexed: 11/27/2022] Open
Abstract
Objective The present study evaluated the efficiency of embryo development and pregnancy of somatic cell nuclear transfer (SCNT) embryos using different source-matured oocytes in Camelus dromedarius. Methods Camelus dromedarius embryos were produced by SCNT using in vivo- and in vitro- matured oocytes. In vitro embryo developmental capacity of reconstructed embryos was evaluated. To confirm the efficiency of pregnancy and live birth rates, a total of 72 blastocysts using in vitro- matured oocytes transferred into 45 surrogates and 95 blastocysts using in vivo- matured oocytes were transferred into 62 surrogates by transvaginal method. Results The collected oocytes derived from ovum pick up showed higher maturation potential into metaphase II oocytes than oocytes from the slaughterhouse. The competence of cleavage, and blastocyst were also significantly higher in in vivo- matured oocytes than in vitro- matured oocytes. After embryo transfer, 11 pregnant and 10 live births were confirmed in in vivo- matured oocytes group, and 2 pregnant and 1 live birth were confirmed in in vitro- matured oocytes group. Furthermore, blastocysts produced by in vivo-matured oocytes resulted in significantly higher early pregnancy and live birth rates than in vitro-matured oocytes. Conclusion In this study, SCNT embryos using in vivo- and in vitro-matured camel oocytes were successfully developed, and pregnancy was established in recipient camels. We also confirmed that in vivo-matured oocytes improved the development of embryos and the pregnancy capacity using the blastocyst embryo transfer method.
Collapse
Affiliation(s)
- Young-Bum Son
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| | - Yeon Ik Jeong
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| | - Yeon Woo Jeong
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| | - Per Olof Olsson
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| | | | - Lian Cai
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| | - Sun Kim
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| | - Eun Ji Choi
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| | - Kenichiro Sakaguchi
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| | - Alex Tinson
- Hilli E.T. Cloning and Surgical Centre Presidential Camels and Camel Racing Affairs, 17292 Al-Ain, United Arab Emirates
| | - Kuhad Kuldip Singh
- Hilli E.T. Cloning and Surgical Centre Presidential Camels and Camel Racing Affairs, 17292 Al-Ain, United Arab Emirates
| | - Singh Rajesh
- Hilli E.T. Cloning and Surgical Centre Presidential Camels and Camel Racing Affairs, 17292 Al-Ain, United Arab Emirates
| | - Al Shamsi Noura
- Hilli E.T. Cloning and Surgical Centre Presidential Camels and Camel Racing Affairs, 17292 Al-Ain, United Arab Emirates
| | - Woo Suk Hwang
- UAE Biotech Research Center, 30310 Al Wathba, Abu Dhabi, United Arab Emirates
| |
Collapse
|
2
|
Aguila L, Suzuki J, Hill ABT, García M, de Mattos K, Therrien J, Smith LC. Dysregulated Gene Expression of Imprinted and X-Linked Genes: A Link to Poor Development of Bovine Haploid Androgenetic Embryos. Front Cell Dev Biol 2021; 9:640712. [PMID: 33869192 PMCID: PMC8044962 DOI: 10.3389/fcell.2021.640712] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2020] [Accepted: 02/25/2021] [Indexed: 11/13/2022] Open
Abstract
Mammalian uniparental embryos are efficient models for genome imprinting research and allow studies on the contribution of the paternal and maternal genomes to early embryonic development. In this study, we analyzed different methods for production of bovine haploid androgenetic embryos (hAE) to elucidate the causes behind their poor developmental potential. Results indicate that hAE can be efficiently generated by using intracytoplasmic sperm injection and oocyte enucleation at telophase II. Although androgenetic haploidy does not disturb early development up to around the 8-cell stage, androgenetic development is disturbed after the time of zygote genome activation and hAE that reach the morula stage are less capable to reach the blastocyst stage of development. Karyotypic comparisons to parthenogenetic- and ICSI-derived embryos excluded chromosomal segregation errors as causes of the developmental constraints of hAE. However, analysis of gene expression indicated abnormal levels of transcripts for key long non-coding RNAs involved in X chromosome inactivation and genomic imprinting of the KCNQ1 locus, suggesting an association with X chromosome and some imprinted loci. Moreover, transcript levels of methyltransferase 3B were significantly downregulated, suggesting potential anomalies in hAE establishing de novo methylation. Finally, the methylation status of imprinted control regions for XIST and KCNQ1OT1 genes remained hypomethylated in hAE at the morula and blastocyst stages, confirming their origin from spermatozoa. Thus, our results exclude micromanipulation and chromosomal abnormalities as major factors disturbing the normal development of bovine haploid androgenotes. In addition, although the cause of the arrest remains unclear, we have shown that the inefficient development of haploid androgenetic bovine embryos to develop to the blastocyst stage is associated with abnormal expression of key factors involved in X chromosome activity and genomic imprinting.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Lawrence C. Smith
- Département de Biomédecine Vétérinaire, Centre de Recherche en Reproduction Et Fertilité, Université de Montreal, Saint-Hyacinthe, QC, Canada
| |
Collapse
|
3
|
Xiao S, Zhang J, Liu M, Iwahata H, Rogers HB, Woodruff TK. Doxorubicin Has Dose-Dependent Toxicity on Mouse Ovarian Follicle Development, Hormone Secretion, and Oocyte Maturation. Toxicol Sci 2018; 157:320-329. [PMID: 28329872 DOI: 10.1093/toxsci/kfx047] [Citation(s) in RCA: 57] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Doxorubicin (DOX), one of the most commonly used anticancer medications, has been reported to affect fertility by damaging ovarian follicles; however, the dose-dependent toxicity of DOX on the dynamic follicle development and oocyte maturation has not been well-defined. Our objective is to determine the effects of human-relevant exposure levels of DOX on follicular functions across developmental time. In vitro cultured multilayered secondary mouse follicles were treated with DOX at 0, 2, 20, 100, and 200 nM for 24 h, and follicle development, hormone secretion, and oocyte maturation were analyzed. DOX caused dose-dependent toxicity on follicle growth, survival, and secretion of 17β-estradiol (E2). At 200 nM, DOX induced DNA damage and apoptosis in follicle somatic cells first and then in oocytes, which was correlated with the uptake of DOX first to the somatic cells followed by germ cells. Follicles treated with DOX at 0, 2, and 20 nM showed similar oocyte metaphase II (MII) percentages after in vitro oocyte maturation; however, 20 nM DOX significantly increased the number of MII oocytes with abnormal spindle morphology and chromosome misalignment. In an effort to harmonize the in vitro study to in vivo treatment, dose-dependent toxicity on oocyte meiotic maturation was found in 16-day-old CD-1 mice treated with DOX at 0, 0.4, 2, and 10 mg/kg, consistent with the in vitro oocyte maturation outcomes. Our study demonstrates that DOX has dose-dependent toxicity on ovarian follicle development, hormone secretion, and oocyte maturation, which are three key factors to support the female reproductive and endocrine functions.
Collapse
Affiliation(s)
- Shuo Xiao
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.,Center for Reproductive Science, Northwestern University, Chicago, Illinois, USA
| | - Jiyang Zhang
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.,Master of Biotechnology Program, Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois, USA
| | - Mingjun Liu
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.,Master of Biotechnology Program, Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois, USA
| | - Hideyuki Iwahata
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.,Center for Reproductive Science, Northwestern University, Chicago, Illinois, USA
| | - Hunter B Rogers
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.,Center for Reproductive Science, Northwestern University, Chicago, Illinois, USA
| | - Teresa K Woodruff
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.,Center for Reproductive Science, Northwestern University, Chicago, Illinois, USA
| |
Collapse
|
4
|
Zhao HC, Ding T, Ren Y, Li TJ, Li R, Fan Y, Yan J, Zhao Y, Li M, Yu Y, Qiao J. Role of Sirt3 in mitochondrial biogenesis and developmental competence of human in vitro matured oocytes. Hum Reprod 2016; 31:607-22. [PMID: 26787646 DOI: 10.1093/humrep/dev345] [Citation(s) in RCA: 59] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2014] [Accepted: 12/22/2015] [Indexed: 01/05/2023] Open
Abstract
STUDY QUESTION Does Sirt3 dysfunction result in poor developmental outcomes for human oocytes after in vitro maturation (IVM)? SUMMARY ANSWER Inefficient Sirt3 expression induced decreased mitochondrial DNA copy number and biogenesis, and therefore impaired the developmental competence of human IVM oocytes. WHAT IS KNOWN ALREADY Cytoplasmic immaturity in IVM oocytes may lead to reduced developmental competence. Mitochondrial dysfunction results in the accumulation of free radicals and leads to DNA mutations, protein damage, telomere shortening and apoptosis. SIRT3 (in the Sirtuin protein family) has emerged as a mitochondrial fidelity protein that directs energy generation and regulates reactive oxygen species scavenging proteins. STUDY DESIGN, SIZE, DURATION In vivo matured metaphase II (IVO-MII) oocytes and IVM-MII oocytes were donated by 324 infertile patients undergoing assisted reproductive technology cycles (12 patients for 60 IVO oocytes, and 312 patients for 403 IVM oocytes). Five oocytes each in the germinal vesicle (GV), IVM and IVO groups were compared with respect to mRNA levels for Sirt1-7 mRNA, and five samples at each developmental stage were analysed for Sirt3 mRNA. IVM-MII oocytes were injected with in vitro transcribed mRNA (n = 59) or small interfering RNA (siRNA) (n = 78). In human and mouse, IVM, mRNA-injection IVM, and siRNA-injection IVM groups (n = 5 each) were analysed for mitochondrial DNA copy number and abundance of Sirt3 and Pgc1α (an inducer of mitochondrial biogenesis) mRNAs. Human blastocysts in the IVO (n = 12), IVM (n = 9), mRNA-injection IVM (n = 13) and siRNA-injection IVM (n = 6) groups were used to generate embryonic stem cells (ESCs). In addition, 587 IVO-MII and 1737 IVM-MII oocytes from 83 mice were collected to compare the preliminary human oocyte data with another species. PARTICIPANTS/MATERIALS, SETTING, METHODS mRNA abundance was analysed by single-cell real-time PCR. Karyotyping of human embryos was performed with an array comparative genomic hybridization method, and that of ESCs by cytogenetic analysis. The function of the Sirt3 gene was investigated using siRNA and in vitro transcribed mRNA injection. Markers of ESCs were identified using immunofluorescence. MAIN RESULTS AND THE ROLE OF CHANCE A retrospective analysis revealed a higher spontaneous abortion rate (P < 0.01) and decrease in high quality embryo rate (P < 0.01) in patients with IVM versus controlled ovarian stimulation (COS) cycles. A decrease in abundance of Sirt3 mRNA (P < 0.01) and mitochondrial biogenesis (P < 0.05) were identified in human IVM compared with IVO oocytes. The developmental potential of human IVM-MII oocytes to the blastocyst stage was significantly reduced when Sirt3 mRNA was inhibited by siRNA (P < 0.05 versus IVM-MII group) but could be up-regulated by injection of Sirt3 mRNAs. Compared with IVO-MII group, comparable generation efficiency of human ESCs can be obtained using blastocysts from IVM-MII oocytes with Sirt3 mRNA injection. Sirt3 mRNA was significantly increased in mouse zygotes after IVF (P < 0.001 versus MII oocytes) but gradually declined until the blastocyst stage. In mice, lower Sirt3 mRNA levels were observed IVM-MII oocytes and preimplantation embryos compared with in vivo controls, and mitochondrial biogenesis and the developmental efficiency from oocytes to blastocyst were affected by the abundance of Sirt3 mRNA in accordance with human. Therefore a similar role for Sirt3 mRNA in IVM-MII oocytes was observed in mouse and human. LIMITATIONS, REASONS FOR CAUTION The couples in the study had a variety of different simple and complex factors causing infertility. Additional studies with a larger number of oocytes are required to confirm the present results owing to the limited number of human oocytes in the present study. WIDER IMPLICATIONS OF THE FINDINGS To our knowledge, this is the first study investigating a role of the Sirt3 gene in mitochondrial biogenesis and the developmental competence of human IVM-MII oocytes. The observation may help to improve clinical application of the IVM procedure. STUDY FUNDING/COMPETING INTERESTS This work was supported in part by the National Natural Science Foundation of Key Program (31230047), Ministry of Science and Technology of China Grants (973 program; 2014CB943203), the National Natural Science Foundation of General Program (31371521 and 81571400), Beijing Nova Program (xxjh2015011), and Specialized Research Fund for the Doctoral Program of Higher Education (20120001130008) and the National Natural Science Foundation of Young Scholar (31501201). The authors have declared that no conflict of interest exists.
Collapse
Affiliation(s)
- Hong-Cui Zhao
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China
| | - Ting Ding
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing 100191, China Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China
| | - Yun Ren
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China
| | - Tian-Jie Li
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China
| | - Rong Li
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing 100191, China Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China
| | - Yong Fan
- Key Laboratory for Major Obstetric Diseases of Guangdong Province, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China
| | - Jie Yan
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing 100191, China
| | - Yue Zhao
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China
| | - Mo Li
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing 100191, China Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China
| | - Yang Yu
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing 100191, China Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China
| | - Jie Qiao
- Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing 100191, China Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China
| |
Collapse
|
5
|
Xiao S, Duncan FE, Bai L, Nguyen CT, Shea LD, Woodruff TK. Size-specific follicle selection improves mouse oocyte reproductive outcomes. Reproduction 2015; 150:183-92. [PMID: 26116002 DOI: 10.1530/rep-15-0175] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2015] [Accepted: 06/18/2015] [Indexed: 12/14/2022]
Abstract
Encapsulated in vitro follicle growth (eIVFG) has great potential to provide an additional fertility preservation option for young women and girls with cancer or other reproductive health threatening diseases. Currently, follicles are cultured for a defined period of time and analyzed as a cohort. However, follicle growth is not synchronous, and culturing follicles for insufficient or excessive times can result in compromised gamete quality. Our objective is to determine whether the selection of follicles based on size, rather than absolute culture time, better predict follicle maturity and oocyte quality. Multilayer secondary mouse follicles were isolated and encapsulated in 0.25% alginate. Follicles were cultured individually either for defined time periods or up to specific follicle diameter ranges, at which point several reproductive endpoints were analyzed. The metaphase II (MII) percentage after oocyte maturation on day 6 was the highest (85%) when follicles were cultured for specific days. However, if follicles were cultured to a terminal diameter of 300-350 μm irrespective of absolute time in culture, 93% of the oocytes reached MII. More than 90% of MII oocytes matured from follicles with diameters of 300-350 μm showed normal spindle morphology and chromosome alignment, 85% of oocytes showed two pronuclei after IVF, 81% developed into the two-cell embryo stage and 38% developed to the blastocyst stage, all significantly higher than the percentages in the other follicle size groups. Our study demonstrates that size-specific follicle selection can be used as a non-invasive marker to identify high-quality oocytes and improve reproductive outcomes during eIVFG.
Collapse
Affiliation(s)
- Shuo Xiao
- Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Francesca E Duncan
- Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Lu Bai
- Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Catherine T Nguyen
- Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Lonnie D Shea
- Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Teresa K Woodruff
- Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA Department of Obstetrics and GynecologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USACenter for Reproductive ScienceNorthwestern University, Evanston, Illinois 60208, USADepartment of Anatomy and Cell BiologyUniversity of Kansas Medical Center, Kansas City, Kansas 66160, USAMaster of Biotechnology ProgramNorthwestern University, Evanston, Illinois 60628, USADepartment of Biomedical EngineeringCollege of Engineering and Medical School, University of Michigan, Ann Arbor, Michigan 48109, USA
| |
Collapse
|
6
|
Epidermal growth factor-mediated mitogen-activated protein kinase3/1 pathway is conducive to in vitro maturation of sheep oocytes. PLoS One 2015; 10:e0120418. [PMID: 25799554 PMCID: PMC4370456 DOI: 10.1371/journal.pone.0120418] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2014] [Accepted: 01/21/2015] [Indexed: 01/01/2023] Open
Abstract
Epidermal growth factor (EGF) has been shown to facilitate the in vitro maturation of sheep oocytes, and enhance embryo’s capability for further development. However, such kind of molecular mechanism has not yet been elucidated. In the present study, we investigated the effect of EGF-mediated mitogen-activated protein kinases 3 and 1 (MAPK3/1) pathway on in vitro maturation of sheep oocytes. U0126, a specific inhibitor of MEK (MAPK kinase), was added into the maturation culture medium to block the EGF-mediated MAPK3/1 pathway with different doses. Then, the nuclear maturation of sheep oocytes was examined. Additionally, the effect of EGF-mediated MAPK3/1 on cytoplasmic maturation was examined though in vitro fertilization and embryonic development. The rate of germinal vesicle breakdown (GVBD) after 6 h of culture with 10−4 mol/l of U0126 (50.4%) was significantly decreased compared with control (67.2%, p < 0.05), and the first polation body (PB1) extrusion rate after 22 h of culture in drug treatment was also significantly inhibited compared with control (28.6% vs. 48.4%, p < 0.05). However, 10−6 mol/l U0126 had slight effect on oocyte nuclear maturation. The normal distribution rate of α-tubulin in the oocytes after 22 h of in vitro maturation was significantly decreased in the 10−4 mol/l U0126 group (54%) compared with control (68%, p < 0.05). After in vitro fertilization, the cleavage rate in drug treatments (56.8% in 10−6 mol/l U0126 group and 42.6% in 10−4 mol/l U0126 group) was significantly decreased compared with control (72.3%, p < 0.01). The blastocyst rate in 10−4 mol/l U0126 group (17.6%) was also significantly decreased compared with control (29.9%, p < 0.05). Collectively, these results suggest that EGF-mediated MAPK3/1 pathway is conducive to in vitro maturation of sheep oocytes.
Collapse
|
7
|
Changes in the expression of DNA double strand break repair genes in primordial follicles from immature and aged rats. Reprod Biomed Online 2015; 30:303-10. [DOI: 10.1016/j.rbmo.2014.11.010] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2014] [Revised: 11/14/2014] [Accepted: 11/18/2014] [Indexed: 11/19/2022]
|